Literature DB >> 34419742

Evaluation of SuperCAZ/AVI® Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates.

Mustafa Sadek1, Laurent Poirel2, Manuel Dominguez Pino1, Fernando D'Emidio3, Stefano Pomponio3, Patrice Nordmann4.   

Abstract

The industrial version of SuperCAZ/AVI® medium developed for screening CAZ/AVI resistant Gram-negative isolates has been evaluated here using a collection of 87 well-characterized clinical isolates of worldwide origin. In addition, testing was performed by spiking stools with a series of resistant and susceptible isolates. In those conditions, the SuperCAZ/AVI® medium exhibited a sensitivity and specificity of 100 %, down to the lower limit of detection of 101 to 102 CFU/ml. The SuperCAZ/AVI® medium is a sensitive and specific screening medium for detection of CZA-resistant bacteria regardless of their resistance mechanisms.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34419742     DOI： 10.1016/j.diagmicrobio.2021.115475

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  1 in total

1.  Implementation of Chromatic Super CAZ/AVI® medium for active surveillance of ceftazidime-avibactam resistance: preventing the loop from becoming a spiral.

Authors:  Gabriele Bianco; Matteo Boattini; Sara Comini; Alessio Leone; Alessandro Bondi; Teresa Zaccaria; Rossana Cavallo; Cristina Costa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-08-06       Impact factor: 5.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.